SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients

Autor: Jan Basri Adiprasito, Tobias Nowacki, Richard Vollenberg, Jörn Arne Meier, Florian Rennebaum, Tina Schomacher, Jonel Trebicka, Julia Fischer, Eva U. Lorentzen, Phil-Robin Tepasse

Publikováno v: Antibodies, Vol 13, Iss 3, p 78 (2024)

In the spring of 2020, the SARS-CoV-2 pandemic presented a formidable challenge to national and global healthcare systems. Immunocompromised individuals or those with relevant pre-existing conditions were particularly at risk of severe coronavirus di

Externí odkaz: https://doaj.org/article/fe0b8f15854644d5ae5e0421baec4c66

Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects

Autor: Richard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, Tobias Max Nowacki, Jörn Arne Meier, Jonel Trebicka, Phil-Robin Tepasse

Publikováno v: Vaccines, Vol 11, Iss 9, p 1411 (2023)

Introduction: The COVID-19 pandemic is a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccination against COVID-19 is crucial for preventing severe illness and controlling the pandemic. This study aimed to examine how immun

Externí odkaz: https://doaj.org/article/b606464b15354920b8b0a7d692869321

Serum levels of ferritin and transferrin serve as prognostic factors for mortality and survival in patients with end-stage liver disease: A propensity score-matched cohort study

Autor: Jörn Arne Meier, Friederike Cordes, Iyad Kabar, Anna Hüsing-Kabar, Hartmut Schmidt, Valentin Fuhrmann, Arne Bokemeyer

Publikováno v: United European Gastroenterol J

BACKGROUND: Patients with end-stage liver disease are known to suffer from a significantly high risk of mortality, but accurate prediction of the course of disease is challenging. OBJECTIVE: The study aim was to evaluate the independent prognostic an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4c1ae4a12c99ba4f6c03e629aadd9d
https://pubmed.ncbi.nlm.nih.gov/32213016

Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients.

Autor: Traska, Ann-Kristin¹ (AUTHOR) ann-kristin.traska@ukmuenster.de, Nowacki, Tobias Max² (AUTHOR) tobias.nowacki@ukm-mhs.de, Vollenberg, Richard¹ (AUTHOR) richard.vollenberg@ukmuenster.de, Rennebaum, Florian¹ (AUTHOR) florian.rennebaum@ukmuenster.de, Meier, Jörn Arne¹ (AUTHOR) joernarne.meier@ukmuenster.de, Schomacher, Tina¹ (AUTHOR) tina.schomacher@ukmuenster.de, Reinartz Groba, Sara Noemi¹ (AUTHOR) saranoemi.reinartzgroba@ukmuenster.de, Fischer, Julia¹ (AUTHOR) julia.fischer2@ukmuenster.de, Trebicka, Jonel¹ (AUTHOR) jonel.trebicka@ukmuenster.de, Tepasse, Phil-Robin¹ (AUTHOR) phil-robin.tepasse@ukmuenster.de

Publikováno v: Cells (2073-4409). May2024, Vol. 13 Issue 9, p741. 14p.

Risk Factors for Infectious Complications following Endoscopic Retrograde Cholangiopancreatography in Liver Transplant Patients: A Single-Center Study.

Autor: Kühl, Norman¹ (AUTHOR) norman.kuehl@ukmuenster.de, Vollenberg, Richard² (AUTHOR) richard.vollenberg@ukmuenster.de, Meier, Jörn Arne² (AUTHOR) joernarne.meier@ukmuenster.de, Ullerich, Hansjörg² (AUTHOR) hansjoerg.ullerich@ukmuenster.de, Schulz, Martin Sebastian² (AUTHOR) martinsebastian.schulz@ukmuenster.de, Rennebaum, Florian² (AUTHOR) florian.rennebaum@ukmuenster.de, Laleman, Wim^2,3 (AUTHOR) wim.laleman@uzleuven.be, Froböse, Neele Judith⁴ (AUTHOR) neelejudith.froboese@ukmuenster.de, Praktiknjo, Michael² (AUTHOR) michael.praktiknjo@ukmuenster.de, Peiffer, Kai² (AUTHOR) kai-henrik.peiffer@ukmuenster.de, Fischer, Julia² (AUTHOR) julia.fischer2@ukmuenster.de, Trebicka, Jonel² (AUTHOR) jonel.trebicka@ukmuenster.de, Gu, Wenyi² (AUTHOR) wenyi.gu@ukmuenster.de, Tepasse, Phil-Robin² (AUTHOR) phil-robin.tepasse@ukmuenster.de

Publikováno v: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 5, p1438. 14p.